{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:18:49Z","timestamp":1788293929631,"version":"build-2803163510"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["project 407495230"],"award-info":[{"award-number":["project 407495230"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["project 423957469"],"award-info":[{"award-number":["project 423957469"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004563","name":"Bayerisches Staatsministerium f\u00fcr Bildung und Kultus, Wissenschaft und Kunst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004563","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The insulin-like growth factor 2 mRNA-binding protein (IGF2BP) family is overexpressed in cancer and associated with poor prognosis. IGF2BP2 has been linked to single metabolic alterations by acting on its RNA targets. Here, we used a comprehensive approach to elucidate the effects of IGF2BP2 on primary and lipid metabolism.\n                    <jats:sup>13<\/jats:sup>\n                    C-metabolic flux analysis (MFA) combined with RNA-Seq data revealed that IGF2BP2 affects mitochondrial fluxes by regulating the expression of several mitochondrial transporters, such as mitochondrial pyruvate carrier 1 (MPC1) and uncoupling protein 2 (UCP2). Methyl pyruvate reversed the gene expression patterns of\n                    <jats:italic>UCP2<\/jats:italic>\n                    and\n                    <jats:italic>CPT1A<\/jats:italic>\n                    in HCT116\n                    <jats:italic>IGF2BP2<\/jats:italic>\n                    knockout (KO) cells by bypassing MPC1. Interestingly, an altered expression of the transporter UCP2 was also observed in a patient-derived tumor organoid (PDO), in which IGF2BP2 was knocked down. The altered glutamine metabolism seen in the\n                    <jats:sup>13<\/jats:sup>\n                    C-MFA and the citrate label data derived from extracted mitochondria confirm a rerouting of glutamine almost exclusively into the mitochondria and a reduction of glycolytic carbon intake into the mitochondria. Due to changes in palmitate labeling patterns, lipid stainings were performed, suggesting lipid accumulation in KO cells. A lipidomic analysis revealed altered compositions across almost all lipid species. Further, lipogenic genes involved in fatty acid and cholesterol metabolism were differentially expressed. Most of the differentially expressed genes are potential direct targets of IGF2BP2 based on publicly available IGF2BP2 CLIP data. Overall, these results show the influence of IGF2BP2 on the central carbon metabolism of cancer cells, primarily through its effects on MPC1 and the resulting effects on UCP2. The complex interaction of IGF2BP2 with the metabolic network provides important insights into tumor metabolism, particularly relevant to tumor growth and resistance to therapy.\n                  <\/jats:p>","DOI":"10.1038\/s41420-026-03315-4","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:57:14Z","timestamp":1788285434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The insulin-like growth factor 2 mRNA-binding protein 2 affects tumor cell metabolism via mitochondrial transporter activity and lipid alterations"],"prefix":"10.1038","volume":"12","author":[{"given":"Sandra","family":"Kendzia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5503-2614","authenticated-orcid":false,"given":"Marcello","family":"Pirritano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Grafahrend-Belau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Bauchspiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Franzenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3651-392X","authenticated-orcid":false,"given":"Marcus","family":"H\u00f6ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2152-2791","authenticated-orcid":false,"given":"Elia","family":"Raab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linus","family":"Schmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinem","family":"S\u00fcrmeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Erdmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Klose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Kleeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Boettcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Liebisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josch K.","family":"Pauling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0962-7788","authenticated-orcid":false,"given":"Martin","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn H.","family":"Junker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8591-851X","authenticated-orcid":false,"given":"Sonja M.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"3315_CR1","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.tem.2020.05.007","volume":"31","author":"N Dai","year":"2020","unstructured":"Dai N. The diverse functions of IMP2\/IGF2BP2 in metabolism. Trends Endocrinol Metab. 2020;31:670\u20139.","journal-title":"Trends Endocrinol Metab"},{"key":"3315_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1021\/acschembio.1c00833","volume":"17","author":"C Dahlem","year":"2022","unstructured":"Dahlem C, Abuhaliema A, Kessler SM, Krohler T, Zoller BGE, Chanda S, et al. First small-molecule inhibitors targeting the RNA-binding protein IGF2BP2\/IMP2 for cancer therapy. ACS Chem Biol. 2022;17:361\u201375.","journal-title":"ACS Chem Biol"},{"key":"3315_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01799-x","volume":"21","author":"J Wang","year":"2021","unstructured":"Wang J, Chen L, Qiang P. The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers. Cancer Cell Int. 2021;21:99.","journal-title":"Cancer Cell Int"},{"key":"3315_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4217259","volume":"2018","author":"J Cao","year":"2018","unstructured":"Cao J, Mu Q, Huang H. The roles of insulin-like growth factor 2 mRNA-binding protein 2 in cancer and cancer stem cells. Stem Cells Int. 2018;2018:4217259.","journal-title":"Stem Cells Int"},{"key":"3315_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01787-x","volume":"22","author":"S Kendzia","year":"2023","unstructured":"Kendzia S, Franke S, Krohler T, Golob-Schwarzl N, Schweiger C, Toeglhofer AM, et al. A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer. Mol Cancer. 2023;22:89.","journal-title":"Mol Cancer"},{"key":"3315_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.241","volume":"6","author":"SM Kessler","year":"2015","unstructured":"Kessler SM, Laggai S, Barghash A, Schultheiss CS, Lederer E, Artl M, et al. IMP2\/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype. Cell Death Dis. 2015;6:e1894.","journal-title":"Cell Death Dis"},{"key":"3315_CR7","doi-asserted-by":"crossref","unstructured":"Dahlem C, Barghash A, Puchas P, Haybaeck J, Kessler SM. The insulin-like growth factor 2 mRNA binding protein IMP2\/IGF2BP2 is overexpressed and correlates with poor survival in pancreatic cancer. Int J Mol Sci. 2019;20:2962.","DOI":"10.3390\/ijms20133204"},{"key":"3315_CR8","first-page":"1079a","volume":"58","author":"SM Kessler","year":"2013","unstructured":"Kessler SM, Lederer E, Reihs R, Kiemer AK, Hayback J. Overexpression of the insulin-like growth factor 2 (IGF2) mRNA binding protein (IMP) p62 as a marker of poor outcome in gallbladder cancer. Hepatology. 2013;58:1079a\u2013a.","journal-title":"Hepatology"},{"key":"3315_CR9","doi-asserted-by":"publisher","first-page":"S433","DOI":"10.1016\/S0168-8278(13)61057-0","volume":"58","author":"SM Kessler","year":"2013","unstructured":"Kessler SM, Haybaeck J, Kiemer AK. The insulin-like growth factor 2 (IGF2) mRNA binding protein (IMP) p62 promotes hepatocarcinogenesis in a transgenic mouse model. J Hepatol. 2013;58:S433\u2013S.","journal-title":"J Hepatol"},{"key":"3315_CR10","doi-asserted-by":"publisher","first-page":"S407","DOI":"10.1016\/S0168-8278(15)30485-2","volume":"62","author":"SM Kessler","year":"2015","unstructured":"Kessler SM, Czepukojc B, Engel K, Van Hul N, Haybaeck J, Leclercq I, et al. The insulin-like growth factor 2 (Igf2) mRNA binding protein (Imp) p62 promotes cirrhosis-linked hepatocarcinogenesis. J Hepatol. 2015;62:S407\u2013S.","journal-title":"J Hepatol"},{"key":"3315_CR11","doi-asserted-by":"publisher","first-page":"49743","DOI":"10.18632\/oncotarget.10439","volume":"7","author":"A Barghash","year":"2016","unstructured":"Barghash A, Golob-Schwarzl N, Helms V, Haybaeck J, Kessler SM. Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2\/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma. Oncotarget. 2016;7:49743\u201350.","journal-title":"Oncotarget"},{"key":"3315_CR12","doi-asserted-by":"crossref","unstructured":"Dai N, Ji F, Wright J, Minichiello L, Sadreyev R, Avruch J. IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1. Elife. 2017;6:e27155.","DOI":"10.7554\/eLife.27155"},{"key":"3315_CR13","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1007\/s00018-012-1186-z","volume":"70","author":"JL Bell","year":"2013","unstructured":"Bell JL, Wachter K, Muhleck B, Pazaitis N, Kohn M, Lederer M, et al. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? Cell Mol Life Sci. 2013;70:2657\u201375.","journal-title":"Cell Mol Life Sci"},{"key":"3315_CR14","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1111\/febs.13614","volume":"283","author":"A Maity","year":"2016","unstructured":"Maity A, Das B. N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases. FEBS J. 2016;283:1607\u201330.","journal-title":"FEBS J"},{"key":"3315_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","volume":"18","author":"BS Zhao","year":"2017","unstructured":"Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18:31\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3315_CR16","doi-asserted-by":"publisher","first-page":"11944","DOI":"10.1074\/jbc.RA119.008778","volume":"294","author":"L Regue","year":"2019","unstructured":"Regue L, Minichiello L, Avruch J, Dai N. Liver-specific deletion of IGF2 mRNA binding protein-2\/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation. J Biol Chem. 2019;294:11944\u201351.","journal-title":"J Biol Chem"},{"key":"3315_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cmet.2015.03.006","volume":"21","author":"N Dai","year":"2015","unstructured":"Dai N, Zhao L, Wrighting D, Kramer D, Majithia A, Wang Y, et al. IGF2BP2\/IMP2-Deficient mice resist obesity through enhanced translation of Ucp1 mRNA and other mRNAs encoding mitochondrial proteins. Cell Metab. 2015;21:609\u201321.","journal-title":"Cell Metab"},{"key":"3315_CR18","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jhep.2010.08.034","volume":"54","author":"E Tybl","year":"2011","unstructured":"Tybl E, Shi FD, Kessler SM, Tierling S, Walter J, Bohle RM, et al. Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype. J Hepatol. 2011;54:994\u20131001.","journal-title":"J Hepatol"},{"key":"3315_CR19","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1194\/jlr.M045500","volume":"55","author":"S Laggai","year":"2014","unstructured":"Laggai S, Kessler SM, Boettcher S, Lebrun V, Gemperlein K, Lederer E, et al. The IGF2 mRNA binding protein p62\/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis. J Lipid Res. 2014;55:1087\u201397.","journal-title":"J Lipid Res"},{"key":"3315_CR20","doi-asserted-by":"publisher","first-page":"S514","DOI":"10.1016\/S0168-8278(13)61271-4","volume":"58","author":"S Laggai","year":"2013","unstructured":"Laggai S, Kessler SM, Gemperlein K, Haybaeck J, Mueller R, Kiemer AK. Altered fatty acid profile in livers overexpressing the IGF2 mRNA binding protein p62: induction of fatty acid elongase ELOVL6 via IGF2-dependend SREP1 activation. J Hepatol. 2013;58:S514\u2013S.","journal-title":"J Hepatol"},{"key":"3315_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01190-w","volume":"19","author":"C Shen","year":"2020","unstructured":"Shen C, Xuan B, Yan T, Ma Y, Xu P, Tian X, et al. m(6)A-dependent glycolysis enhances colorectal cancer progression. Mol Cancer. 2020;19:72.","journal-title":"Mol Cancer"},{"key":"3315_CR22","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/abbs\/gmz048","volume":"51","author":"S Huang","year":"2019","unstructured":"Huang S, Wu Z, Cheng Y, Wei W, Hao L. Insulin-like growth factor 2 mRNA binding protein 2 promotes aerobic glycolysis and cell proliferation in pancreatic ductal adenocarcinoma via stabilizing GLUT1 mRNA. Acta Biochim Biophys Sin. 2019;51:743\u201352.","journal-title":"Acta Biochim Biophys Sin"},{"key":"3315_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1105-0","volume":"18","author":"Y Wang","year":"2019","unstructured":"Wang Y, Lu JH, Wu QN, Jin Y, Wang DS, Chen YX, et al. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Mol Cancer. 2019;18:174.","journal-title":"Mol Cancer"},{"key":"3315_CR24","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1101\/gad.188292.112","volume":"26","author":"M Janiszewska","year":"2012","unstructured":"Janiszewska M, Suva ML, Riggi N, Houtkooper RH, Auwerx J, Clement-Schatlo V, et al. Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells. Genes Dev. 2012;26:1926\u201344.","journal-title":"Genes Dev"},{"key":"3315_CR25","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1093\/bioinformatics\/btu015","volume":"30","author":"JD Young","year":"2014","unstructured":"Young JD. INCA: a computational platform for isotopically non-stationary metabolic flux analysis. Bioinformatics. 2014;30:1333\u20135.","journal-title":"Bioinformatics"},{"key":"3315_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ymben.2021.12.009","volume":"69","author":"M Rahim","year":"2022","unstructured":"Rahim M, Ragavan M, Deja S, Merritt ME, Burgess SC, Young JD. INCA 2.0: a tool for integrated, dynamic modeling of NMR- and MS-based isotopomer measurements and rigorous metabolic flux analysis. Metab Eng. 2022;69:275\u201385.","journal-title":"Metab Eng"},{"key":"3315_CR27","doi-asserted-by":"crossref","unstructured":"Warburg O. \u00dcber den Stoffwechsel der Tumoren. Berlin: Springer; 1928.","DOI":"10.1007\/978-3-642-47774-4_21"},{"key":"3315_CR28","doi-asserted-by":"publisher","first-page":"e1005618","DOI":"10.1371\/journal.pcbi.1005618","volume":"13","author":"HQ Wu","year":"2017","unstructured":"Wu HQ, Cheng ML, Lai JM, Wu HH, Chen MC, Liu WH, et al. Flux balance analysis predicts Warburg-like effects of mouse hepatocyte deficient in miR-122a. PLoS Comput Biol. 2017;13:e1005618.","journal-title":"PLoS Comput Biol"},{"key":"3315_CR29","doi-asserted-by":"crossref","unstructured":"Owen JB, Butterfield DA. Measurement of oxidized\/reduced glutathione ratio. In: Bross P, Gregersen N, editors. Protein misfolding and cellular stress in disease and aging: concepts and protocols. Totowa (NJ): Humana Press; 2010. p. 269\u201377.","DOI":"10.1007\/978-1-60761-756-3_18"},{"key":"3315_CR30","doi-asserted-by":"crossref","unstructured":"Kohler N, Rose TD, Falk L, Pauling JK. Investigating global lipidome alterations with the Lipid Network Explorer. Metabolites. 2021;11:488.","DOI":"10.3390\/metabo11080488"},{"key":"3315_CR31","doi-asserted-by":"crossref","unstructured":"Rose TD, Kohler N, Falk L, Klischat L, Lazareva OE, Pauling JK. Lipid network and moiety analysis for revealing enzymatic dysregulation and mechanistic alterations from lipidomics data. Brief Bioinform. 2023;24:bbad018.","DOI":"10.1093\/bib\/bbac572"},{"key":"3315_CR32","doi-asserted-by":"crossref","unstructured":"Hofmanova J, Slavik J, Ciganek M, Ovesna P, Tylichova Z, Karasova M, et al. Complex alterations of fatty acid metabolism and phospholipidome uncovered in isolated colon cancer epithelial cells. Int J Mol Sci. 2021;22:6632.","DOI":"10.3390\/ijms22136650"},{"key":"3315_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s13340-020-00481-3","volume":"12","author":"T Matsuzaka","year":"2021","unstructured":"Matsuzaka T. Role of fatty acid elongase Elovl6 in the regulation of energy metabolism and pathophysiological significance in diabetes. Diabetol Int. 2021;12:68\u201373.","journal-title":"Diabetol Int"},{"key":"3315_CR34","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/nm1662","volume":"13","author":"T Matsuzaka","year":"2007","unstructured":"Matsuzaka T, Shimano H, Yahagi N, Kato T, Atsumi A, Yamamoto T, et al. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nat Med. 2007;13:1193\u2013202.","journal-title":"Nat Med"},{"key":"3315_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0330-6","volume":"9","author":"YA Wen","year":"2018","unstructured":"Wen YA, Xiong X, Zaytseva YY, Napier DL, Vallee E, Li AT, et al. Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer. Cell Death Dis. 2018;9:265.","journal-title":"Cell Death Dis"},{"key":"3315_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bbabio.2004.12.005","volume":"1707","author":"JC Hildyard","year":"2005","unstructured":"Hildyard JC, Ammala C, Dukes ID, Thomson SA, Halestrap AP. Identification and characterisation of a new class of highly specific and potent inhibitors of the mitochondrial pyruvate carrier. Biochim Biophys Acta. 2005;1707:221\u201330.","journal-title":"Biochim Biophys Acta"},{"key":"3315_CR37","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.molcel.2014.09.025","volume":"56","author":"C Yang","year":"2014","unstructured":"Yang C, Ko B, Hensley CT, Jiang L, Wasti AT, Kim J, et al. Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. Mol Cell. 2014;56:414\u201324.","journal-title":"Mol Cell"},{"key":"3315_CR38","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.1073\/pnas.1303360110","volume":"110","author":"AS Divakaruni","year":"2013","unstructured":"Divakaruni AS, Wiley SE, Rogers GW, Andreyev AY, Petrosyan S, Loviscach M, et al. Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier. Proc Natl Acad Sci USA 2013;110:5422\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3315_CR39","doi-asserted-by":"publisher","first-page":"G328","DOI":"10.1152\/ajpgi.00005.2012","volume":"304","author":"SM Kessler","year":"2013","unstructured":"Kessler SM, Pokorny J, Zimmer V, Laggai S, Lammert F, Bohle RM, et al. IGF2 mRNA binding protein p62\/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2\/PI3K signaling. Am J Physiol Gastrointest Liver Physiol. 2013;304:G328\u201336.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3315_CR40","doi-asserted-by":"publisher","first-page":"89736","DOI":"10.18632\/oncotarget.21116","volume":"8","author":"SM Kessler","year":"2017","unstructured":"Kessler SM, Lederer E, Laggai S, Golob-Schwarzl N, Hosseini K, Petzold J, et al. IMP2\/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer. Oncotarget. 2017;8:89736\u201345.","journal-title":"Oncotarget"},{"key":"3315_CR41","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/1873-3468.12205","volume":"590","author":"S Ye","year":"2016","unstructured":"Ye S, Song W, Xu X, Zhao X, Yang L. IGF2BP2 promotes colorectal cancer cell proliferation and survival through interfering with RAF-1 degradation by miR-195. FEBS Lett. 2016;590:1641\u201350.","journal-title":"FEBS Lett"},{"key":"3315_CR42","doi-asserted-by":"crossref","unstructured":"Shen J, Ding Y. Multifaceted roles of insulin-like growth factor 2 mRNA binding protein 2 in human cancer (Review). Mol Med Rep. 2025;31:123.","DOI":"10.3892\/mmr.2025.13441"},{"key":"3315_CR43","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.7150\/ijbs.122142","volume":"22","author":"HS Schymik","year":"2026","unstructured":"Schymik HS, Wrublewsky S, Horing M, Liebisch G, Both S, Gasparoni G, et al. IGF2BP2 deficiency in macrophages impairs migration, reprograms metabolism, and limits tumor progression. Int J Biol Sci. 2026;22:2754\u201373.","journal-title":"Int J Biol Sci"},{"key":"3315_CR44","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1016\/S0021-9258(18)95956-9","volume":"242","author":"DE Atkinson","year":"1967","unstructured":"Atkinson DE, Walton GM. Adenosine triphosphate conservation in metabolic regulation. J Biol Chem. 1967;242:3239\u201341.","journal-title":"J Biol Chem"},{"key":"3315_CR45","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","volume":"40","author":"H Weng","year":"2022","unstructured":"Weng H, Huang F, Yu Z, Chen Z, Prince E, Kang Y, et al. The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell. 2022;40:1566\u201382.e10.","journal-title":"Cancer Cell"},{"key":"3315_CR46","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285\u201395.","journal-title":"Nat Cell Biol"},{"key":"3315_CR47","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.copbio.2013.04.016","volume":"24","author":"JD Young","year":"2013","unstructured":"Young JD. Metabolic flux rewiring in mammalian cell cultures. Curr Opin Biotechnol. 2013;24:1108\u201315.","journal-title":"Curr Opin Biotechnol"},{"key":"3315_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ymben.2017.02.002","volume":"43","author":"W Dong","year":"2017","unstructured":"Dong W, Keibler MA, Stephanopoulos G. Review of metabolic pathways activated in cancer cells as determined through isotopic labeling and network analysis. Metab Eng. 2017;43:113\u201324.","journal-title":"Metab Eng"},{"key":"3315_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109512","volume":"36","author":"FA Ladha","year":"2021","unstructured":"Ladha FA, Thakar K, Pettinato AM, Legere N, Ghahremani S, Cohn R, et al. Actinin BioID reveals sarcomere crosstalk with oxidative metabolism through interactions with IGF2BP2. Cell Rep. 2021;36:109512.","journal-title":"Cell Rep"},{"key":"3315_CR50","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1182\/blood.2021012197","volume":"139","author":"M Suo","year":"2022","unstructured":"Suo M, Rommelfanger MK, Chen Y, Amro EM, Han B, Chen Z, et al. Agedependent effects of Igf2bp2 on gene regulation, function, and aging of hematopoietic stem cells in mice. Blood. 2022;139:2653\u201365.","journal-title":"Blood"},{"key":"3315_CR51","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.bbabio.2009.01.003","volume":"1787","author":"F Bouillaud","year":"2009","unstructured":"Bouillaud F. UCP2, not a physiologically relevant uncoupler but a glucose sparing switch impacting ROS production and glucose sensing. Biochim Biophys Acta. 2009;1787:377\u201383.","journal-title":"Biochim Biophys Acta"},{"key":"3315_CR52","doi-asserted-by":"publisher","first-page":"74364","DOI":"10.1155\/2007\/74364","volume":"2007","author":"F Villarroya","year":"2007","unstructured":"Villarroya F, Iglesias R, Giralt M. PPARs in the control of uncoupling proteins gene expression. PPAR Res. 2007;2007:74364.","journal-title":"PPAR Res"},{"key":"3315_CR53","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1210\/en.2005-0817","volume":"147","author":"H Oberkofler","year":"2006","unstructured":"Oberkofler H, Klein K, Felder TK, Krempler F, Patsch W. Role of peroxisome proliferator-activated receptor-gamma coactivator-1alpha in the transcriptional regulation of the human uncoupling protein 2 gene in INS-1E cells. Endocrinology. 2006;147:966\u201376.","journal-title":"Endocrinology"},{"key":"3315_CR54","doi-asserted-by":"publisher","first-page":"32434","DOI":"10.1074\/jbc.M503152200","volume":"280","author":"S Mizuarai","year":"2005","unstructured":"Mizuarai S, Miki S, Araki H, Takahashi K, Kotani H. Identification of dicarboxylate carrier Slc25a10 as malate transporter in de novo fatty acid synthesis. J Biol Chem. 2005;280:32434\u201341.","journal-title":"J Biol Chem"},{"key":"3315_CR55","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1042\/BJ20080709","volume":"413","author":"S Jitrapakdee","year":"2008","unstructured":"Jitrapakdee S, St Maurice M, Rayment I, Cleland WW, Wallace JC, Attwood PV. Structure, mechanism and regulation of pyruvate carboxylase. Biochem J. 2008;413:369\u201387.","journal-title":"Biochem J"},{"key":"3315_CR56","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/ncb3233","volume":"17","author":"S Cardaci","year":"2015","unstructured":"Cardaci S, Zheng L, MacKay G, van den Broek NJ, MacKenzie ED, Nixon C, et al. Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis. Nat Cell Biol. 2015;17:1317\u201326.","journal-title":"Nat Cell Biol"},{"key":"3315_CR57","doi-asserted-by":"crossref","unstructured":"Halestrap AP, Denton RM. Specific inhibition of pyruvate transport in rat liver mitochondria and human erythrocytes by alpha-cyano-4-hydroxycinnamate. Biochem J. 1974;138:313\u20136.","DOI":"10.1042\/bj1380313"},{"key":"3315_CR58","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.molcel.2014.09.024","volume":"56","author":"NM Vacanti","year":"2014","unstructured":"Vacanti NM, Divakaruni AS, Green CR, Parker SJ, Henry RR, Ciaraldi TP, et al. Regulation of substrate utilization by the mitochondrial pyruvate carrier. Mol Cell. 2014;56:425\u201335.","journal-title":"Mol Cell"},{"key":"3315_CR59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12944-019-0977-8","volume":"18","author":"A Pakiet","year":"2019","unstructured":"Pakiet A, Kobiela J, Stepnowski P, Sledzinski T, Mika A. Changes in lipids composition and metabolism in colorectal cancer: a review. Lipids Health Dis. 2019;18:29.","journal-title":"Lipids Health Dis"},{"key":"3315_CR60","doi-asserted-by":"publisher","first-page":"e0228010","DOI":"10.1371\/journal.pone.0228010","volume":"15","author":"J Hofmanova","year":"2020","unstructured":"Hofmanova J, Slavik J, Ovesna P, Tylichova Z, Dusek L, Strakova N, et al. Phospholipid profiling enables to discriminate tumor- and non-tumor-derived human colon epithelial cells: phospholipidome similarities and differences in colon cancer cell lines and in patient-derived cell samples. PLoS One. 2020;15:e0228010.","journal-title":"PLoS One"},{"key":"3315_CR61","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1158\/0008-5472.CAN-19-4035","volume":"80","author":"N Abbassi-Ghadi","year":"2020","unstructured":"Abbassi-Ghadi N, Antonowicz SS, McKenzie JS, Kumar S, Huang J, Jones EA, et al. De novo lipogenesis alters the phospholipidome of esophageal adenocarcinoma. Cancer Res. 2020;80:2764\u201374.","journal-title":"Cancer Res"},{"key":"3315_CR62","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1158\/0008-5472.CAN-13-2852","volume":"74","author":"SM Kessler","year":"2014","unstructured":"Kessler SM, Laggai S, Barghash A, Helms V, Kiemer AK. Lipid metabolism signatures in NASH-associated HCC.-letter. Cancer Res. 2014;74:2903\u20134.","journal-title":"Cancer Res"},{"key":"3315_CR63","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/ijc.29517","volume":"137","author":"E Marien","year":"2015","unstructured":"Marien E, Meister M, Muley T, Fieuws S, Bordel S, Derua R, et al. Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles. Int J Cancer. 2015;137:1539\u201348.","journal-title":"Int J Cancer"},{"key":"3315_CR64","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11010-012-1523-4","volume":"374","author":"N Azordegan","year":"2013","unstructured":"Azordegan N, Fraser V, Le K, Hillyer LM, Ma DW, Fischer G, et al. Carcinogenesis alters fatty acid profile in breast tissue. Mol Cell Biochem. 2013;374:223\u201332.","journal-title":"Mol Cell Biochem"},{"key":"3315_CR65","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s11658-025-00723-9","volume":"30","author":"S Liu","year":"2025","unstructured":"Liu S, Liao S, He J, Zhou Y, He Q. IGF2BP2: an m(6)A reader that affects cellular function and disease progression. Cell Mol Biol Lett. 2025;30:43.","journal-title":"Cell Mol Biol Lett"},{"key":"3315_CR66","doi-asserted-by":"crossref","unstructured":"Yang M, Gallo-Ebert C, Hayward M, Liu W, McDonough V, Nickels JT Jr. Human insulin growth factor 2 mRNA binding protein 2 increases microRNA 33a\/b inhibition of liver ABCA1 expression and alters low-density apolipoprotein levels in mice. Mol Cell Biol. 2020;40:e00058\u201320.","DOI":"10.1128\/MCB.00058-20"},{"key":"3315_CR67","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F Rohrig","year":"2016","unstructured":"Rohrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16:732\u201349.","journal-title":"Nat Rev Cancer"},{"key":"3315_CR68","doi-asserted-by":"publisher","first-page":"8117","DOI":"10.1158\/0008-5472.CAN-09-3871","volume":"70","author":"E Rysman","year":"2010","unstructured":"Rysman E, Brusselmans K, Scheys K, Timmermans L, Derua R, Munck S, et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res. 2010;70:8117\u201326.","journal-title":"Cancer Res"},{"key":"3315_CR69","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1053\/j.gastro.2021.05.009","volume":"161","author":"J Ecker","year":"2021","unstructured":"Ecker J, Benedetti E, Kindt ASD, Horing M, Perl M, Machmuller AC, et al. The colorectal cancer lipidome: identification of a robust tumor-specific lipid species signature. Gastroenterology. 2021;161:910\u201323.e19.","journal-title":"Gastroenterology"},{"key":"3315_CR70","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/cam4.711","volume":"5","author":"H Wang","year":"2016","unstructured":"Wang H, Xi Q, Wu G. Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathway. Cancer Med. 2016;5:1599\u2013606.","journal-title":"Cancer Med"},{"key":"3315_CR71","doi-asserted-by":"publisher","first-page":"25578","DOI":"10.1074\/jbc.270.43.25578","volume":"270","author":"MK Bennett","year":"1995","unstructured":"Bennett MK, Lopez JM, Sanchez HB, Osborne TF. Sterol regulation of fatty acid synthase promoter. Coordinated feedback regulation of two major lipid pathways. J Biol Chem. 1995;270:25578\u201383.","journal-title":"J Biol Chem"},{"key":"3315_CR72","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1073\/pnas.93.3.1049","volume":"93","author":"JM Lopez","year":"1996","unstructured":"Lopez JM, Bennett MK, Sanchez HB, Rosenfeld JM, Osborne TF. Sterol regulation of acetyl coenzyme A carboxylase: a mechanism for coordinate control of cellular lipid. Proc Natl Acad Sci USA 1996;93:1049\u201353.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3315_CR73","doi-asserted-by":"publisher","first-page":"12497","DOI":"10.1074\/jbc.275.17.12497","volume":"275","author":"R Sato","year":"2000","unstructured":"Sato R, Okamoto A, Inoue J, Miyamoto W, Sakai Y, Emoto N, et al. Transcriptional regulation of the ATP citrate-lyase gene by sterol regulatory element-binding proteins. J Biol Chem. 2000;275:12497\u2013502.","journal-title":"J Biol Chem"},{"key":"3315_CR74","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7:763\u201377.","journal-title":"Nat Rev Cancer"},{"key":"3315_CR75","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0092-8674(05)80095-9","volume":"75","author":"C Yokoyama","year":"1993","unstructured":"Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, et al. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 1993;75:187\u201397.","journal-title":"Cell"},{"key":"3315_CR76","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0022-2275(20)30465-X","volume":"43","author":"T Matsuzaka","year":"2002","unstructured":"Matsuzaka T, Shimano H, Yahagi N, Yoshikawa T, Amemiya-Kudo M, Hasty AH, et al. Cloning and characterization of a mammalian fatty acyl-CoA elongase as a lipogenic enzyme regulated by SREBPs. J Lipid Res. 2002;43:911\u201320.","journal-title":"J Lipid Res"},{"key":"3315_CR77","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/cbf.3067","volume":"32","author":"M Caputo","year":"2014","unstructured":"Caputo M, De Rosa MC, Rescigno T, Zirpoli H, Vassallo A, De Tommasi N, et al. Binding of polyunsaturated fatty acids to LXRalpha and modulation of SREBP-1 interaction with a specific SCD1 promoter element. Cell Biochem Funct. 2014;32:637\u201346.","journal-title":"Cell Biochem Funct"},{"key":"3315_CR78","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.stem.2016.11.004","volume":"20","author":"J Li","year":"2017","unstructured":"Li J, Condello S, Thomes-Pepin J, Ma X, Xia Y, Hurley TD, et al. Lipid desaturation is a metabolic marker and therapeutic target of ovarian cancer stem cells. Cell Stem Cell. 2017;20:303\u201314.e5.","journal-title":"Cell Stem Cell"},{"key":"3315_CR79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1194\/jlr.M076752","volume":"59","author":"S Cruz-Gil","year":"2018","unstructured":"Cruz-Gil S, Sanchez-Martinez R, Gomez de Cedron M, Martin-Hernandez R, Vargas T, Molina S, et al. Targeting the lipid metabolic axis ACSL\/SCD in colorectal cancer progression by therapeutic miRNAs: miR-19b-1 role. J Lipid Res. 2018;59:14\u201324.","journal-title":"J Lipid Res"},{"key":"3315_CR80","doi-asserted-by":"publisher","first-page":"e33823","DOI":"10.1371\/journal.pone.0033823","volume":"7","author":"P Mason","year":"2012","unstructured":"Mason P, Liang B, Li L, Fremgen T, Murphy E, Quinn A, et al. SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids. PloS ONE. 2012;7:e33823.","journal-title":"PloS ONE"},{"key":"3315_CR81","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1159\/000458431","volume":"41","author":"A Mika","year":"2017","unstructured":"Mika A, Kobiela J, Czumaj A, Chmielewski M, Stepnowski P, Sledzinski T. Hyper-elongation in colorectal cancer tissue - cerotic acid is a potential novel serum metabolic marker of colorectal malignancies. Cell Physiol Biochem. 2017;41:722\u201330.","journal-title":"Cell Physiol Biochem"},{"key":"3315_CR82","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","volume":"53","author":"J Berger","year":"2002","unstructured":"Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med. 2002;53:409\u201335.","journal-title":"Annu Rev Med"},{"key":"3315_CR83","doi-asserted-by":"publisher","first-page":"115","DOI":"10.33549\/physiolres.930744","volume":"55","author":"MM Haluzik","year":"2006","unstructured":"Haluzik MM, Haluzik M. PPAR-alpha and insulin sensitivity. Physiol Res. 2006;55:115\u201322.","journal-title":"Physiol Res"},{"key":"3315_CR84","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ejmech.2019.01.067","volume":"166","author":"AZ Mirza","year":"2019","unstructured":"Mirza AZ, Althagafi II, Shamshad H. Role of PPAR receptor in different diseases and their ligands: physiological importance and clinical implications. Eur J Med Chem. 2019;166:502\u201313.","journal-title":"Eur J Med Chem"},{"key":"3315_CR85","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.bbalip.2007.04.018","volume":"1771","author":"KA Burns","year":"2007","unstructured":"Burns KA, Vanden Heuvel JP. Modulation of PPAR activity via phosphorylation. Biochim Biophys Acta. 2007;1771:952\u201360.","journal-title":"Biochim Biophys Acta"},{"key":"3315_CR86","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1023\/B:PHAM.0000041444.06122.8d","volume":"21","author":"DH van Raalte","year":"2004","unstructured":"van Raalte DH, Li M, Pritchard PH, Wasan KM. Peroxisome proliferator-activated receptor (PPAR)- : a pharmacological target with a promising future. Pharm Res. 2004;21:1531\u20138.","journal-title":"Pharm Res"},{"key":"3315_CR87","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.critrevonc.2016.11.007","volume":"109","author":"N Rodriguez-Salas","year":"2017","unstructured":"Rodriguez-Salas N, Dominguez G, Barderas R, Mendiola M, Garcia-Albeniz X, Maurel J, et al. Clinical relevance of colorectal cancer molecular subtypes. Crit Rev Oncol Hematol. 2017;109:9\u201319.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3315_CR88","doi-asserted-by":"crossref","unstructured":"Aparicio J, Esposito F, Serrano S, Falco E, Escudero P, Ruiz-Casado A, et al. Metastatic colorectal cancer. First line therapy for unresectable disease. J Clin Med. 2020;9:3811.","DOI":"10.3390\/jcm9123889"},{"key":"3315_CR89","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0002-9440(10)61770-1","volume":"159","author":"MNR Lu","year":"2001","unstructured":"Lu MNR, Dent ED, Zhang JY, Nielsen FC, Christiansen J, Chan EK, et al. Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis. Am J Pathol. 2001;159:945\u201353.","journal-title":"Am J Pathol"},{"key":"3315_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-13-295","volume":"13","author":"CH Poskar","year":"2012","unstructured":"Poskar CH, Huege J, Krach C, Franke M, Shachar-Hill Y, Junker BH. iMS2Flux-a high-throughput processing tool for stable isotope labeled mass spectrometric data used for metabolic flux analysis. BMC Bioinforma. 2012;13:295.","journal-title":"BMC Bioinforma"},{"key":"3315_CR91","unstructured":"Voet DV, Voet JG, Pratt CW. Lehrbuch der Biochemie. 3rd ed. Weinheim: Wiley-VCH; 2019. 1491 p."},{"key":"3315_CR92","unstructured":"Horn FMI, Schneider N, Grillh\u00f6sl C, Berghold S, Lindenmeier G. Biochemie des Menschen. 4th ed. Stuttgart: Georg Thieme Verlag; 2009."},{"key":"3315_CR93","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/j.2040-4603.2014.tb00548.x","volume":"4","author":"L Rui","year":"2014","unstructured":"Rui L. Energy metabolism in the liver. Compr Physiol. 2014;4:177\u201397.","journal-title":"Compr Physiol"},{"key":"3315_CR94","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrendo.2017.80","volume":"13","author":"MC Petersen","year":"2017","unstructured":"Petersen MC, Vatner DF, Shulman GI. Regulation of hepatic glucose metabolism in health and disease. Nat Rev Endocrinol. 2017;13:572\u201387.","journal-title":"Nat Rev Endocrinol"},{"key":"3315_CR95","doi-asserted-by":"publisher","first-page":"D498","DOI":"10.1093\/nar\/gkaa1025","volume":"49","author":"A Chang","year":"2021","unstructured":"Chang A, Jeske L, Ulbrich S, Hofmann J, Koblitz J, Schomburg I, et al. BRENDA, the ELIXIR core data resource in 2021: new developments and updates. Nucleic Acids Res. 2021;49:D498\u2013508.","journal-title":"Nucleic Acids Res"},{"key":"3315_CR96","doi-asserted-by":"crossref","unstructured":"Romero P, Wagg J, Green ML, Kaiser D, Krummenacker M, Karp PD. Computational prediction of human metabolic pathways from the complete human genome. Genome Biol. 2004;6:R2.","DOI":"10.1186\/gb-2004-6-1-r2"},{"key":"3315_CR97","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"MKAS Goto","year":"2000","unstructured":"Goto MKAS. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"3315_CR98","doi-asserted-by":"publisher","first-page":"D471","DOI":"10.1093\/nar\/gkv1164","volume":"44","author":"R Caspi","year":"2016","unstructured":"Caspi R, Billington R, Ferrer L, Foerster H, Fulcher CA, Keseler IM, et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway\/genome databases. Nucleic Acids Res. 2016;44:D471\u201380.","journal-title":"Nucleic Acids Res"},{"key":"3315_CR99","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.taap.2009.07.005","volume":"240","author":"J Niklas","year":"2009","unstructured":"Niklas J, Noor F, Heinzle E. Effects of drugs in subtoxic concentrations on the metabolic fluxes in human hepatoma cell line Hep G2. Toxicol Appl Pharm. 2009;240:327\u201336.","journal-title":"Toxicol Appl Pharm"},{"key":"3315_CR100","doi-asserted-by":"publisher","first-page":"33425","DOI":"10.1074\/jbc.M109.049478","volume":"284","author":"Y Noguchi","year":"2009","unstructured":"Noguchi Y, Young JD, Aleman JO, Hansen ME, Kelleher JK, Stephanopoulos G. Effect of anaplerotic fluxes and amino acid availability on hepatic lipoapoptosis. J Biol Chem. 2009;284:33425\u201336.","journal-title":"J Biol Chem"},{"key":"3315_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-8-50","volume":"8","author":"A Nicolae","year":"2014","unstructured":"Nicolae A, Wahrheit J, Bahnemann J, Zeng AP, Heinzle E. Non-stationary 13C metabolic flux analysis of Chinese hamster ovary cells in batch culture using extracellular labeling highlights metabolic reversibility and compartmentation. BMC Syst Biol. 2014;8:50.","journal-title":"BMC Syst Biol"},{"key":"3315_CR102","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/tpj.12142","volume":"74","author":"SK Masakapalli","year":"2013","unstructured":"Masakapalli SK, Kruger NJ, Ratcliffe RG. The metabolic flux phenotype of heterotrophic Arabidopsis cells reveals a complex response to changes in nitrogen supply. Plant J. 2013;74:569\u201382.","journal-title":"Plant J"},{"key":"3315_CR103","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ymben.2006.09.001","volume":"9","author":"MR Antoniewicz","year":"2007","unstructured":"Antoniewicz MR, Kelleher JK, Stephanopoulos G. Elementary metabolite units (EMU): a novel framework for modeling isotopic distributions. Metab Eng. 2007;9:68\u201386.","journal-title":"Metab Eng"},{"key":"3315_CR104","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/bit.21632","volume":"99","author":"JD Young","year":"2008","unstructured":"Young JD, Walther JL, Antoniewicz MR, Yoo H, Stephanopoulos G. An elementary metabolite unit (EMU) based method of isotopically nonstationary flux analysis. Biotechnol Bioeng. 2008;99:686\u201399.","journal-title":"Biotechnol Bioeng"},{"key":"3315_CR105","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ymben.2006.01.004","volume":"8","author":"MR Antoniewicz","year":"2006","unstructured":"Antoniewicz MR, Kelleher JK, Stephanopoulos G. Determination of confidence intervals of metabolic fluxes estimated from stable isotope measurements. Metab Eng. 2006;8:324\u201337.","journal-title":"Metab Eng"},{"key":"3315_CR106","first-page":"10","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnetjournal. 2011;17:10\u20132.","journal-title":"EMBnetjournal"},{"key":"3315_CR107","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","volume":"25","author":"C Trapnell","year":"2009","unstructured":"Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009;25:1105\u201311.","journal-title":"Bioinformatics"},{"key":"3315_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"3315_CR109","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020;36:2628\u20139.","journal-title":"Bioinformatics"},{"key":"3315_CR110","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45:D353\u2013D61.","journal-title":"Nucleic Acids Res"},{"key":"3315_CR111","doi-asserted-by":"crossref","unstructured":"Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034.","DOI":"10.1186\/gb-2002-3-7-research0034"},{"key":"3315_CR112","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/y59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911\u20137.","journal-title":"Can J Biochem Physiol"},{"key":"3315_CR113","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbalip.2005.12.007","volume":"1761","author":"G Liebisch","year":"2006","unstructured":"Liebisch G, Binder M, Schifferer R, Langmann T, Schulz B, Schmitz G. High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS\/MS). Biochim Biophys Acta. 2006;1761:121\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"3315_CR114","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1093\/clinchem\/48.12.2217","volume":"48","author":"G Liebisch","year":"2002","unstructured":"Liebisch G, Drobnik W, Lieser B, Schmitz G. High-throughput quantification of lysophosphatidylcholine by electrospray ionization tandem mass spectrometry. Clin Chem. 2002;48:2217\u201324.","journal-title":"Clin Chem"},{"key":"3315_CR115","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","volume":"49","author":"V Matyash","year":"2008","unstructured":"Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res. 2008;49:1137\u201346.","journal-title":"J Lipid Res"},{"key":"3315_CR116","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/S0022-2275(20)33398-8","volume":"40","author":"G Liebisch","year":"1999","unstructured":"Liebisch G, Drobnik W, Reil M, Tr\u00fcmbach B, Arnecke R, Olgem\u00f6ller B, et al. Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS\/MS). J Lipid Res. 1999;40:1539\u201346.","journal-title":"J Lipid Res"},{"key":"3315_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2021.100050","volume":"62","author":"M Horing","year":"2021","unstructured":"Horing M, Ejsing CS, Krautbauer S, Ertl VM, Burkhardt R, Liebisch G. Accurate quantification of lipid species affected by isobaric overlap in Fourier-transform mass spectrometry. J Lipid Res. 2021;62:100050.","journal-title":"J Lipid Res"},{"key":"3315_CR118","doi-asserted-by":"publisher","first-page":"10966","DOI":"10.1021\/acs.analchem.0c02408","volume":"92","author":"M Horing","year":"2020","unstructured":"Horing M, Ekroos K, Baker PRS, Connell L, Stadler SC, Burkhardt R, et al. Correction of isobaric overlap resulting from sodiated ions in lipidomics. Anal Chem. 2020;92:10966\u201370.","journal-title":"Anal Chem"},{"key":"3315_CR119","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1021\/acs.analchem.8b05013","volume":"91","author":"M Horing","year":"2019","unstructured":"Horing M, Ejsing CS, Hermansson M, Liebisch G. Quantification of cholesterol and cholesteryl ester by direct flow injection high-resolution fourier transform mass spectrometry utilizing species-specific response factors. Anal Chem. 2019;91:3459\u201366.","journal-title":"Anal Chem"},{"key":"3315_CR120","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1194\/jlr.S120001025","volume":"61","author":"G Liebisch","year":"2020","unstructured":"Liebisch G, Fahy E, Aoki J, Dennis EA, Durand T, Ejsing CS, et al. Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures. J Lipid Res. 2020;61:1539\u201355.","journal-title":"J Lipid Res"},{"key":"3315_CR121","doi-asserted-by":"publisher","first-page":"13129","DOI":"10.1073\/pnas.0506716102","volume":"102","author":"AB Castoreno","year":"2005","unstructured":"Castoreno AB, Wang Y, Stockinger W, Jarzylo LA, Du H, Pagnon JC, et al. Transcriptional regulation of phagocytosis-induced membrane biogenesis by sterol regulatory element binding proteins. PNAS. 2005;102:13129\u201334.","journal-title":"PNAS"},{"key":"3315_CR122","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1016\/j.bbadis.2018.05.024","volume":"1864","author":"A Dehghani Amirabad","year":"2018","unstructured":"Dehghani Amirabad A, Ramasamy P, Wierz M, Nordstrom K, Kessler SM, Schulz MH, et al. Transgenic expression of the RNA binding protein IMP2 stabilizes miRNA targets in murine microsteatosis. Biochim Biophys Acta Mol Basis Dis. 2018;1864:3099\u2013108.","journal-title":"Biochim Biophys Acta Mol Basis Dis"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03315-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03315-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03315-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:02:28Z","timestamp":1788292948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03315-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":122,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3315"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03315-4","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"For patient-derived organoid culture tumor material from a CRC patient was used. Informed consent was obtained from all human subjects included in the study. The study was approved by the local ethics committee of the University of Halle (#2019-037). All methods were carried out in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"353"}}